液体生検の世界市場分析:用途別(転移性乳がん(MBS)の治療選択、他の転移性がんの治療選択、分子モニタリング、分子モニタリング)、サンプル別(血液、尿、組織および唾液)、バイオマーカー別(循環腫瘍細胞(CTC)、循環腫瘍DNA(ctDNA)、エキソソーム)、技術別(単一遺伝子解析(PCRマイクロアレイ)、多遺伝子並列分析(NGS))、動向分析、2013-2030...市場調査レポートについてご紹介

【英文タイトル】Liquid Biopsy Market Size & Forecast By Application (Therapy Selection for Metastatic Breast Cancer (MBS), Therapy Selection for Other Metastatic Cancers, Molecular Monitoring, Molecular Monitoring), By Sample Type (Blood, Urine, Tissue & Saliva), By Biomarker Type (Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes), By Technology (Single Gene Analysis (PCR Microarrays), Multi-gene-parallel Analysis (NGS)) And Trend Analysis from 2013 To 2030

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & Growth Prospect Mapping
4.5. SWOT Analysis, By Factor
4.5.1. Political
4.5.2. Economic
4.5.3. Technological
4.6. Industry Analysis – Porter’s
4.7. Competitive Landscape & Market Share Analysis, 2015 & 2030
4.8. Liquid Biopsy Pipeline Analysis, 2015 – 2020
Chapter 5. Market Categorization 1: Application Estimates & Trend Analysis
5.1. Application Movement Analysis & Market Share, 2015, 2020 & 2030
5.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following applications:
5.2.1. Therapy Selection for Metastatic Breast Cancer (MBS)
5.2.2. Therapy Selection for Other Metastatic Cancer
5.2.3. Molecular Health Monitoring
Chapter 6. Market Categorization 2: Sample Type Estimates & Trend Analysis
6.1. Sample Type Movement Analysis & Market Share, 2015, 2020 & 2030
6.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following sample types:
6.2.1. Blood Samples
6.2.2. Urine Samples
6.2.3. Other Bio fluids (Tissue fluids and Saliva)
Chapter 7. Market Categorization 3: Biomarker Estimates & Trend Analysis
7.1. Biomarker Movement Analysis & Market Share, 2015, 2020 & 2030
7.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following biomarkers:
7.2.1. Circulating Tumor Cells (CTC)
7.2.2. Circulating Tumor DNA (ctDNA)
7.2.3. Exosomes (Macrovesicles with Protein, RNA, DNA)
Chapter 8. Market Categorization 4: Technology Estimates & Trend Analysis
8.1. Technology Movement Analysis & Market Share, 2015, 2020 & 2030
8.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following technologies:
8.2.1. Multi-gene parallel Analysis using NGS
8.2.2. Single Gene Analysis using PCR Microarrays
Chapter 9. Market Categorization 3: Regional Estimates & Trend Analysis
9.1. Regional Movement Analysis & Market Share, 2015, 2020 & 2030
9.2. North America
9.2.1. North America revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. North America revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.2.2.1. U.S.
9.2.2.2. Canada
9.2.3. North America revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.2.3.1. U.S.
9.2.3.2. Canada
9.2.4. North America revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.2.4.1. U.S.
9.2.4.2. Canada
9.3. Europe
9.3.1. Europe revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.3.1.1. Germany
9.3.1.2. UK
9.3.2. Europe revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.3.2.1. Germany
9.3.2.2. UK
9.3.3. Europe revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.3.3.1. Germany
9.3.3.2. UK
9.3.4. Europe revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.3.4.1. Germany
9.3.4.2. UK
9.4. Asia Pacific
9.4.1. Asia Pacific revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.4.1.1. Japan
9.4.1.2. China
9.4.2. Asia Pacific revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.4.2.1. Japan
9.4.2.2. China
9.4.3. Asia Pacific revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.4.3.1. Japan
9.4.3.2. China
9.4.4. Asia Pacific revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.4.4.1. Japan
9.4.4.2. China
9.5. Latin America
9.5.1. Latin America revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.5.1.1. Brazil
9.5.2. Latin America revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.5.2.1. Brazil
9.5.3. Latin America revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.5.3.1. Brazil
9.5.4. Latin America revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.5.4.1. Brazil
9.6. Middle East & Africa
9.6.1. Middle East & Africa revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.6.1.1. South Africa
9.6.2. Middle East & Africa revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.6.2.1. South Africa
9.6.3. Middle East & Africa revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.6.3.1. South Africa
9.6.4. Middle East & Africa revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.6.4.1. South Africa
Chapter 10. Competitive Landscape
10.1. Adaptive Biotechnologies
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. Biocept
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Strategic Initiatives
10.3. Guardant Health
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Strategic Initiatives
10.4. NeoGenomics Laboratories
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Strategic Initiatives
10.5. Personal Genome Diagnostics
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Strategic Initiatives
10.6. Qiagen
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Strategic Initiatives
10.7. RainDance Technologies
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Strategic Initiatives
10.8. Trovagene
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Strategic Initiatives
10.9. Cynvenio
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Strategic Initiatives
10.10. Epic Sciences
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Strategic Initiatives
10.11. Exosome
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Strategic Initiatives
10.12. Foundation Medicine
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Strategic Initiatives
10.13. Genomic Health
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Strategic Initiatives
10.14. Illumina Inc.
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.4. Strategic Initiatives
10.15. Angle Plc
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Strategic Initiatives
10.16. Boreal Genomics
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Strategic Initiatives
10.17. CareDx
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Strategic Initiatives
10.18. Chronix Biomedical
10.18.1. Company Overview
10.18.2. Financial Performance
10.18.3. Product Benchmarking
10.18.4. Strategic Initiatives
10.19. Cynvenio Biosystems Inc.
10.19.1. Company Overview
10.19.2. Financial Performance
10.19.3. Product Benchmarking
10.19.4. Strategic Initiatives
10.20. Epic Sciences
10.20.1. Company Overview
10.20.2. Financial Performance
10.20.3. Product Benchmarking
10.20.4. Strategic Initiatives
10.21. Foundation Medicine
10.21.1. Company Overview
10.21.2. Financial Performance
10.21.3. Product Benchmarking
10.21.4. Strategic Initiatives
10.22. Natera Inc.
10.22.1. Company Overview
10.22.2. Financial Performance
10.22.3. Product Benchmarking
10.22.4. Strategic Initiatives
10.23. Pathway Genomics
10.23.1. Company Overview
10.23.2. Financial Performance
10.23.3. Product Benchmarking
10.23.4. Strategic Initiatives
10.24. Roche (Ariosa)
10.24.1. Company Overview
10.24.2. Financial Performance
10.24.3. Product Benchmarking
10.24.4. Strategic Initiatives
10.25. Sequenom
10.25.1. Company Overview
10.25.2. Financial Performance
10.25.3. Product Benchmarking
10.25.4. Strategic Initiatives
10.26. Trovagene
10.26.1. Company Overview
10.26.2. Financial Performance
10.26.3. Product Benchmarking
10.26.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:液体生検の世界市場分析:用途別(転移性乳がん(MBS)の治療選択、他の転移性がんの治療選択、分子モニタリング、分子モニタリング)、サンプル別(血液、尿、組織および唾液)、バイオマーカー別(循環腫瘍細胞(CTC)、循環腫瘍DNA(ctDNA)、エキソソーム)、技術別(単一遺伝子解析(PCRマイクロアレイ)、多遺伝子並列分析(NGS))、動向分析、2013-2030
■ 英文:Liquid Biopsy Market Size & Forecast By Application (Therapy Selection for Metastatic Breast Cancer (MBS), Therapy Selection for Other Metastatic Cancers, Molecular Monitoring, Molecular Monitoring), By Sample Type (Blood, Urine, Tissue & Saliva), By Biomarker Type (Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes), By Technology (Single Gene Analysis (PCR Microarrays), Multi-gene-parallel Analysis (NGS)) And Trend Analysis from 2013 To 2030
■ 発行日:2016年9月8日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707486
■ 調査対象地域:グローバル
  • ヨガウェアの世界市場2019-2023
    145 Pages, November 2018 About this market Manufacturers of yoga apparel are continuously introducing types of yoga apparel. They are adopting advanced technology and features to offer better customer satisfaction. Technavio’s analysts have predicted that the global yoga apparel market will register a CAGR of over 6% by 2023. Market overview Growing number of yoga practitioners The purchase volume …
  • バイオPET(ポリエチレンテレフタラート)の世界市場
    About Bio-based Polyethylene Terephthalate Bio-based PET is a biodegradable product made from materials such as monoethylene glycol (MEG) and terephthalic acid (PTA). About 30% of bio-based PETs are composed of monoethylene glycol (MEG), a product of sugarcane ethanol, and the rest is composed of purified terephthalic acid (PTA), a chemical-based product of crude oil. There are different types of …
  • テクスチャード大豆タンパク質の世界市場:性質別(有機、従来、非GMO)、用途別(食品、飲料産業、飼料産業)
    The global textured soy protein market size was valued at $1.1 billion in 2018, and is projected to reach $2.1 billion by 2026, registering a CAGR of 8.7% from 2019 to 2026. Textured soy protein or textured vegetable protein is obtained from defatted soy flour. Defatted soy flour is made by grinding defatted soy flakes, which is obtain by removing oil from soybeans. Textured soy protein is availab …
  • 世界のRDBMS市場動向(2012-2016)
    TechNavio's analysts forecast the Global Relational Database Management System (RDBMS) market to grow at a CAGR of 10.06 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for business intelligence. The Global RDBMS market has also been witnessing an increasing demand for self-managing computing systems. However, issues related to …
  • スマートグリッド市場分析:Analyzing the Smart Grid
    Today’s electric power grid is primarily composed of central generating stations and electromechanical power delivery systems operated from control centers. However, the system is transforming itself into a smart grid that integrates a multitude of distributed energy resources, uses solid state electronics to manage and deliver power, and employs automated control systems. The smart grid will achi …
  • Osteonecrosis:グローバル臨床試験レビューH2, 2013
    Osteonecrosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Osteonecrosis Global Clinical Trials Review, H2, 2013" provides data on the Osteonecrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Osteonecrosis. It includes an overview of the trial numbers and their recruitment status as per the …
  • 屋根断熱材用接着剤の世界市場2017-2021:二成分型、一成分型
    About Roofing Insulation Adhesives Insulation adhesives are expensive than mechanical fasteners. However, adhesives are proven to be cheaper on decks, which require predrilling. This is due to the reduction in the required man hours as the installation of roofing insulating panels using adhesives is faster, thereby reducing the labor costs. Technavio’s analysts forecast the global roofing insulati …
  • ワークスペース・アグリゲータの世界市場2016-2020
    About the Workspace Aggregator Market Workspace aggregator is a client application or a web portal or software that combines any multirole applications, such as Dropbox, Skype, and virtual desktop infrastructure, with devices and data to provide a single point access. The user can work in some or all of workspace components such as software as a service (SaaS) apps, mobile apps, virtual apps, phys …
  • Pakistan Petroleum Limited:石油・ガスの開発・生産動向及びコスト分析– 2012
    Pakistan Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Pakistan Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
  • Migraine:グローバル臨床試験レビューH2, 2013
    Migraine Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Migraine Global Clinical Trials Review, H2, 2013" provides data on the Migraine clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Migraine. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
  • 世界主要国における腸疾患検査市場2015
    Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500.This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.  About this Repo …
  • 放射線量管理製品・サービスの世界市場予測(~2022年)
    The global radiation dose management market is estimated to grow at a CAGR of 42.0% from 2017 to 2022, to reach USD 931.3 million by 2022 from USD 161.3 million in 2017. The growing adoption of EHR systems, increasing initiatives for the implementation of health information exchanges (HIEs), growing awareness on radiation safety, increasing radiation exposure to patients, and increasing number of …
  • プレストレスト・コンクリート(PC)ワイヤ&ストランドの世界市場
    ABSTRACTAbout Prestressed Concrete (PC) Wire and Strand The artificial compression stress applied to neutralize tensile stress deployed by exterior force is known as prestress. The structures constructed with prestress is called PC. The wire or strand used on PC structure is known as PC wire or strand. When force is applied to the concrete, prestressing is introduced to counter the stresses result …
  • 多連装ロケットシステム(MLRS)の世界市場2016-2020
    About MLRS MLRS is an adaptable precision-approach weapon system that complements traditional cannon artillery fires. The system delivers a large volume of firepower along with shoot-and-scoot capability in a short duration against perilous, time-sensitive targets. These targets include mechanized units, air defense systems, enemy artillery, and personnel. Technavio’s analysts forecast the global …
  • X線撮影法の世界市場2017-2021
    About RadiographyRadiography is a technique that uses gamma rays and X-rays to produce images of objects. These images can be used to identify certain deformities or defects that are not visible to the bare eye. The object to be tested is subjected to radiations using a generator, while a film or digital detector is used to take the image of the object. The darker areas on the image indicate high …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。